These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22466918)

  • 1. Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.
    Lopez-Delgado JC; Mendiluce RM; Pinol TS; Fernández XP; Sanchez L; Vicente RG
    Ann Transplant; 2012; 17(1):122-7. PubMed ID: 22466918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
    Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
    Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.
    Jao J; Sturdevant M; del Rio Martin J; Schiano T; Fiel MI; Huprikar S
    Am J Transplant; 2010 Jul; 10(7):1713-6. PubMed ID: 20642694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
    Elsharkawy AM; Schwab U; McCarron B; Burt AD; Daly AK; Hudson M; Masson S
    J Clin Virol; 2013 Sep; 58(1):331-3. PubMed ID: 23763943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)].
    Vennarecci G; Ettorre GM; Antonini M; Maritti M; Moricca P; D'Offizzi G; Narciso P; Lonardo MT; Boschetto A; Del Nonno F; Perracchio L; Palmieri GP; Visco G; Santoro E
    Tumori; 2003; 89(4 Suppl):159-61. PubMed ID: 12903579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic failure due to nevirapine treatment for HIV infection].
    Mens H; Katzenstein TL
    Ugeskr Laeger; 2005 Nov; 167(46):4359. PubMed ID: 16287519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Sha BE; Proia LA; Kessler HA
    JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
    [No Abstract]   [Full Text] [Related]  

  • 8. A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation.
    Turkova A; Ball C; Gilmour-White S; Rela M; Mieli-Vergani G
    J Antimicrob Chemother; 2009 Mar; 63(3):623-5. PubMed ID: 19164417
    [No Abstract]   [Full Text] [Related]  

  • 9. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature.
    Wang B; Abbott L; Childs K; Taylor C; Agarwal K; Cormack I; Miquel R; Suddle A
    Int J STD AIDS; 2018 Mar; 29(4):414-417. PubMed ID: 29059031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine-induced fulminant hepatitis.
    Maniar JK; Shah SR; Verma R; Kamath R; Gupte P; Maniar A
    J Assoc Physicians India; 2006 Dec; 54():957-8. PubMed ID: 17334017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
    Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
    Sulkowski MS; Thomas DL; Mehta SH; Chaisson RE; Moore RD
    Hepatology; 2002 Jan; 35(1):182-9. PubMed ID: 11786975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases.
    Clark SJ; Creighton S; Portmann B; Taylor C; Wendon JA; Cramp ME
    J Hepatol; 2002 Feb; 36(2):295-301. PubMed ID: 11830344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
    Bundow D; Rosoff L; Aboulafia DM
    AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
    Popoola TD; Awodele O; Oshikoya KA
    Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan.
    Tseng YT; Yang CJ; Chang SY; Lin SW; Tsai MS; Liu WC; Wu PY; Su YC; Luo YZ; Yang SP; Hung CC; Chang SC
    Int J Infect Dis; 2014 Dec; 29():12-7. PubMed ID: 25312984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral adverse effects due to the use of Nevirapine.
    Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
    J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.